Inovio Pharmaceuticals Financial Overview
Inovio Pharmaceuticals's market cap is currently $149.09M. The company's EPS TTM is $-0.87; its P/E ratio is ―; Inovio Pharmaceuticals is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
